Gavi Leap
Since the middle of 2024, Gavi began a process of re-examining every aspect of the way it works to prepare for its next strategic period. Learn more about this transformation known as the ‘Gavi Leap’.
Learn more
Since the middle of 2024, Gavi began a process of re-examining every aspect of the way it works to prepare for its next strategic period. Learn more about this transformation known as the ‘Gavi Leap’.
Learn moreGavi's five-year plan
Learn more about the five-year strategy setting out the vision and goals that drive our work.
Learn more about the five-year strategy setting out the vision and goals that drive our work.
Latest news
View allBoard decisions place country ownership at the heart of a new operating model, reflecting key elements of the Gavi Leap transformation agenda.
Gavi and Global Polio Eradication Initiative Boards convene for second joint session
The Boards of Gavi, the Vaccine Alliance (Gavi) and the Global Polio Eradication Initiative (GPEI) convened to further strengthen collaboration and accelerate progress toward shared goals: reaching zero-dose and under-immunized children with…
Morocco pledges US$ 5 million to Gavi, debuts as a donor to global immunisation efforts
Morocco makes a donation to Gavi, pledging US$ 5 million towards its next strategic period.
What is VaccinesWork?
VaccinesWork is an award-winning digital platform hosted by Gavi, the Vaccine Alliance covering news, features and explainers from every corner of global health and immunisation.
Learn more
VaccinesWork is an award-winning digital platform hosted by Gavi, the Vaccine Alliance covering news, features and explainers from every corner of global health and immunisation.
Learn moreVaccinesWork latest
7 things you need to know about the state of malaria today
The World Malaria Report 2024 highlights major progress against malaria driven by vaccines – and the key threats that could derail it.
In Kenya, smaller vaccine vials may mean more children protected
Ten-dose vaccine vials make a lot of sense – until they don’t. In one sub-district hospital, lower-dose measles-rubella vaccine vials are spurring hopes of fewer frustrations and improved coverage.
In a world of finite resources, immunisation advocacy is how Gavi ensures that stakeholders invest in a shared global health security.
